Existing wound infection treatments mainly rely on antibiotics that are inefficient towards drug-resistant bacteria and silver-based wound dressings that often cause skin irritation, delay wound healing, and inactivate bacteria only partially, leading to reoccurring infections and amputations.
Bacterial wound infections cause 10 million amputations every year.
Nanordica Medical has invented and patented a nanoformula enabling to develop 5x more efficient antibacterial products compared to the existing market alternatives.
Nanordica nanoformula has proven antibacterial efficiency confirmed by the North Estonia Medical Centre. Nanoformula can be used to manufacture a wide range of antibacterial products like wound dressings, sprays, creams, catheters or surface coatings.
As the first product, we developed advanced antibacterial wound dressing. We completed preclinical studies, got the feedback from distributors, medical doctors and end-users and started the CE marking process to receive the marketing approval in EU.